The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | G | Genito urinary system and sex hormones | |
| 2 | G03 | Sex hormones and modulators of the genital system | |
| 3 | G03A | Hormonal contraceptives for systemic use | |
| 4 | G03AA | Progestogens and estrogens, fixed combinations | |
| 5 | G03AA07 | Levonorgestrel and ethinylestradiol |
| Title | Information Source | Document Type | |
|---|---|---|---|
| LOETTE Tablet | Medicines and Medical Devices Safety Authority (NZ) | MPI, EU: SmPC | |
| MICROGYNON Sugar-coated tablets | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| RIGEVIDON Coated tablet | Web Search | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
